As a newly identified target of interest [2], Runx1 can be further exploited in basic and translational studies to protect against myocardial ischemia/reperfusion injury and/or to limit the progression of adverse cardiac remodeling, thereby improving therapeutic strategies and patient prognosis of heart diseases. Here, RUNX1 is linked to heart disorder.